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Introduction
Obesity is considered a global epidemic (Report 
WHO, 2008; Report WHO, 2009). The causes of obesity 
are very complex, from bad habits such as intake of high 
amount of fats and simple sugars, via environmental 
conditions, stressogenic and genetic factors, as well as 
the influence of intestinal microbiota and short-chain 
fatty acids. The pathologically increased amount of fat 
causes a number of disorders in the proper functions 
of the systems, organs and tissues. Complications of 
the cardiovascular, respiratory, endocrine system and 
psychosocial problems proved to be particularly dan-
gerous. Obesity is not only a medical problem, which 
directly contributes to 10–13% of premature deaths 
in Europe, but it is also associated with a significant 
economic burden because of the costs associated with 
obesity which in Europe range from 2% to 7%. A major 
problem is the phenomenon of transferring childhood 
obesity to adulthood (Maziak et al. 2007; Report WHO 
2008; Report WHO 2009).
In 2004, Gordon hypothesized that intestinal micro-
biota is associated with body mass control of the host 
(Backhed et al. 2004). According to his assumptions, 
certain groups of bacteria are capable to absorb nutri-
ents and energy more efficiently, and individuals, whose 
intestinal microbiota can rapidly metabolize nutrients, 
absorb more calories and increase body weight much 
easier; therefore, they are prone to obesity. It is believed 
that the specific relative ratio between Bacteroidetes 
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A b s t r a c t
The growing number of children with overweight and obesity constitutes a major health problem of the modern world and it has been 
suggested that intestinal microbiota may influence energy intake from food. The objectives of this study were to determine quantity and 
proportions of dominant genera of Bacteroides, Prevotella (phylum Bacteroidetes); Clostridium, Lactobacillus (phylum Firmicutes) and Bifido­
bacterium (phylum Actinobacteria) in the intestines and to determine the content of short-chain fatty acids (SCFAs) and branched-chain 
fatty acids (BCFAs) in the stool of 20 obese children and 20 children with normal body weight. Strains classified as Firmicutes (Clostridium 
and Lactobacillus) predominated in stool microbiota of obese children, while those of Bacteroidetes (Prevotella and Bacteroides) were in 
minority (p < 0.001). Concentration of SCFAs in the stool of obese children was lower in comparison to the stool of normal weight children 
(p = 0.04). However, these differences were significant only in obese children, not in overweight children in comparison with the lean ones. 
Therefore, in our study obesity was associated with intestinal dysbiosis and a predominance of phylum Firmicutes. Secondly, stool of obese 
children contained lower amounts of SCFAs. 
K e y  w o r d s: Actinobacteria, Bacteroidetes, Firmicutes, BCFAs, obesity, SCFAs
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and Firmicutes, which both constitute 90% of bacte-
ria colonizing the intestines, is associated with obesity. 
The overgrowth of bacteria of phylum Firmicutes with 
simultaneous reduction of bacteria from phylum Bac­
teroidetes was observed in the intestines of both obese 
mice and humans (Backhed et al. 2004; Ley et al. 2006; 
Sanz et al. 2008; De Filippo et al. 2010; Diamant et al. 
2011; Everard et al. 2013, Canfora et al. 2015; Lu et al. 
2016; Raza et al. 2017).
The specific ratio of Bacteroidetes to Firmicutes is 
important for a healthy body weight; and beside this, the 
gut microbiota have many beneficial functions, such as: 
the influence on immunity, stimulation of the microvilli 
development, fermentation of dietary fiber and prebio-
tics: short-chain fatty acids (SCFAs) (butyric, propionic 
and acetic acids) and lactic acid that are very beneficial 
to humans (Neish 2002; Stewart et al. 2004; Cani et al. 
2008; Cani et al. 2009; Walker and Lawley 2013). This 
observation has recently been questioned since differ-
ent studies failed to confirm differences in the Bacteroi­
detes/Firmicutes ratio between lean and obese humans 
(Mondot and Lepage 2016; Lin et al. 2016; Bouter 
et al. 2018). Metabolism of glucose is regulated by the 
gut microbiota. It was shown that the high number of 
bacteria belonging to the Bactero idetes phylum signifi-
cantly affects glucose intolerance, which was caused by 
the consumption of a high-fat diet. However, the high 
Bacteroidetes content had little impact on mouse obesity 
(Rabot et al. 2016). The individual’s microbiota composi-
tion may cause phenotypic variation correlated to mice 
feeding with high-fat diet (Rabot et al. 2016).
SCFAs have many functions; among them, pro pionic 
acid has a positive effect on the growth of hepatocytes 
and acetic acid on the development of peripheral tis-
sues. Butyric acid stimulates the growth of intestinal 
epithelial tissue, nourishes intestinal cells and affects 
their proper maturation and differentiation. SCFAs reg-
ulate also glucose and lipid metabolism, stimulate pro-
liferation and differentiation of intestinal enterocytes, 
contribute to decrease in the pH of intestinal content 
and promote the absorption of minerals by increasing 
their solubility (Blaut and Clavel 2007; Lin et al. 2012). 
The objective of this study was to determine the 
prevalence and proportions of dominant bacteria of 
genera Bacteroides, Prevotella (phylum Bacteroidetes); 
Clostridium, Lactobacillus (phylum Firmicutes) and 
Bifi do bacterium (phylum Actinobacteria) in the intes-
tines as well as to determine the content of short-chain 
fatty acids (acetic, butyric, formic, propionic, valeric) 
and branched-chain fatty acids (isovaleric and isobu-
tyric) in the stool of 20 obese children and 20 children 
with normal body weight. 
Experimental
Materials and methods
Biological material. The stool of 20 children: 
10 overweights (BMI 25,68–29,48) and 10 obese chil-
dren (BMI 31,71–41,18) aged between 6 and 15 years, 
and stool of 20 lean children (BMI 18,5–22,38) in the 
same age range was collected. As many as 55% of over-
weight and obese children lived in the city, while oth-
ers (45%) were from rural areas. Children with normal 
body weight lived mostly in the city (70%) while 30% 
were from rural areas. In the group of overweight and 
obese children, girls and boys accounted for 60% and 
40%, respectively. In the group of children with nor-
mal body weight, girls and boys constituted 65% and 
35%, respectively. In the close family of overweight and 
obese children, one could report overweight or obesity 
in over 95% cases; while in children from family where 
normal body weight was reported – only 15% of fam-
ily members were overweight or obese. Definitions of 
overweight and obesity were based on definition of the 
International Obesity Task Force (IOTF) criteria devel-
oped by Cole et al. (2012). Immediately after the samples 
were taken into sterile containers, the faeces were frozen 
and transported on the same day for further analysis.
Determination of the number of bacteria. The 
number of bacteria was determined with fluorescence 
in situ hybridization (FISH). Hybridization proce-
dure was prepared based on the method described by 
Barczyńska et al. (2017). Hybridization was conducted 
in a humid chamber at a temperature and time specific 
to the oligonucleotide probes applied. Table I shows the 
sequences of probes and hybridization conditions used 
Lab 158 Lactobacillus­Enterococcus  GGT ATT AGC A(T?C)CTGT TTC CA 5’Fluo 46 24
Bif 164 Bifidobacterium spp. CAT CCG GCA TTA CCA CCC 5’Cy3 58 18
Bac 303 Bacteroides­Prevotella CCA ATG TGG GGG ACC TT 5’Cy3 55 3
Erec 484 Clostridium coccoides GCT TCT TAG TCA GGT ACC G 5’Cy3 57 16
Prov Prevotella ATCTTGAGTGAGTTCGATGTTGG 5’Fluo 57 18
Table I
The sequence of oligonucleotide probes and hybridization conditions used in FISH procedure for the identification
of the bacteria present in children faeces.
Probe Identified microorganisms Sequence (5’→3’) Fluorescent label Temp [°C] Time [h]
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for the identification of bacteria by FISH. Microscopic 
observations were performed using Eclipse E-400 fluo-
rescence microscope (Nikon, Japan), combined with 
COHU 4910 camera (Cohu Inc., USA) and coupled 
with a computer. Enumeration of microbial cells was 
performed using NIS Elements BR version 3.2 com-
puter program (Nikon, Japan).
Isolation, amplification, RFLP and sequencing 
of DNA. Isolation of bacteria genomic DNA was per-
formed using kit Genomic Mini (A&A Biotechnology) 
according to the manufacturer’s protocol. The isolated 
DNA was amplified by PCR using oligonucleotides 
specific to bacterial 16S RNA fragments. For sequenc-
ing purposes, the PCR products were purified using 
Exonuclease I (EURx) and Fast Polar-BAP kit (EURx). 
For restriction enzyme length polymorphism analysis 
(RFLP), the PCR products were digested using Taq I 
restriction enzyme (Thermo Scientific) and compared 
to control DNA mass marker. Automated sequencing of 
purified DNA fragments was performed in the Labora-
tory of DNA Sequencing and Oligonucleotides Synthe-
sis at the Institute of Biochemistry and Biophysics of 
Polish Academy of Sciences at Warsaw using 3730 XL 
DNA Analyzer (Applied Biosystem). Sequence data 
of the selected isolates were analyzed and compared to 
sequences of reference strains obtained from Gen Bank 
NCBI base using BLASTN 2.2.32+ program.
Analysis of the content of SCFA and BCFA acids 
by high performance liquid chromatography, HPLC. 
Determination of the concentrations of lactic acid, 
SCFAs (acetic, propionic, butyric, formic, and valeric 
acids) and BCFAs (isobutyric and isovaleric acids) was 
conducted using high performance liquid chromato-
graphy (HPLC) with Surveyor liquid chromatograph 
(Thermo Scientific). Aminex HPX-87H (300 × 7.8 mm) 
(Bio-Rad Aminex®) column filled with styrene-divi-
nylbenzene sulfonated copolymer bed were used. The 
following parameters were used in the analyses: Aminex 
HPX-87H column, mobile phase 0.005 M H2SO4, UV 
detector at a wavelength of 210 nm, rheodyne type 
injection valve, injection of sample – 10 µl, analysis tem-
perature –60°C, flow rate 0.6 µl min–1, analysis time of 
a single sample 35 min. HPLC analysis was performed 
for the samples with known concentrations of appro- 
priate acids, as follows: 0, 0.125, 0.25, 0.50, 0.75 and 1% 
to plot calibration curves, i.e., the concentration of the 
acid in the function of surface area of the peak shown 
in the chromatogram (area). The equations developed 
were based on calibration curves and enabled calcula-
tion of the concentration of short-chain fatty acids in 
the analyzed stool samples.
Statistical analysis. The results were evaluated with 
W-Shapiro Wilk test in order to assess the normality 
of the distribution of the results. Due to the deviation 
from the normal distribution, further analyses were 
performed with use of U Mann-Whitney test. The data 
obtained from the questionnaire were analysed using 
the χ2 test. Statistical significance was established at 
p < 0.05. The statistical analysis was performed using 
STATISTICA 10.0 software (StatSoft, Inc.).
Results
Determination of the number of bacteria of the 
main genera from overweight, obese and normal 
weight children. It was found that in the stool of over-
weight and obese children, among of the five bacteria 
genera tested, those classified as Clostridium predom-
inated and their number was from 7.21 to 8.96 log10 
cells g–1, average 8.03 log10 cells g–1. In the stool of chil-
dren with normal weight, the average amount of these 
bacteria was lower by about 14% (p < 0.01), and their 
number was from 5.42 to 7.92 log10 cells g–1. In the 
stool of children with normal body weight the domi-
nant genera were Bacteroides (their number was from 
6.58 to 10.06 log10 cells g–1, average 8.57 log10 cells g–1) 
and Bifidobacterium (their number was from 6.78 to 
9.52 log10 cells g–1, average was 9.07 log10 cells g–1). In 
overweight and obese children, the number of Bac­
teroides was lower by about 20% (p < 0.01) (6.67 to 
8.0 log10 cells g–1), and Bifidobacterium by about 18% 
(p = 0.036) (6.51 to 8.48 log10 cells g–1). The number of 
Prevotella was higher on average by 30% (p < 0.01) in 
children with normal body weight (the number was 
from 3.25 to 8.98 log10 cells g–1) compared to children 
with obesity (the number was from 3.19 to 5.18 log10 
cells g–1). The average number of Lactobacillus strains in 
the stool of overweight, obese and normal weight chil-
dren was similar and accounted for 7.81 log10 cells g–1 
(6.61 to 9.52 log10 cells g–1), and 7.77 log10 cells g–1 (7.16 
to 8.65 log10 cells g–1), respectively (p = 0.913) (Fig. 1).
Systematizing the strains tested to phyla, it was 
found that in the stool of overweight and obese chil-
dren, bacteria of phylum Firmicutes (Lactobacillus and 
Clostridium genera) accounted for the majority of the 
bacteria tested, on average 45.9%. In the faeces of over-
weight and obese children, the bacteria belonging to 
genera Lactobacillus and Clostridium was similar and 
accounted for 23% of bacteria population from the 
five tested bacteria genera. However, bacteria belong-
ing to phylum Bacteroidetes (Prevotella and Bacteroides 
genera) accounted on average for 32.4% of bacteria. 
Within this phylum Bacteroides dominated (19.89%), 
while Prevotella was in the minority (12.5%). Bifidobac­
terium (phylum Actinobacteria) accounted for 21.7% 
of the bacteria. In the stool of children with normal 
weight, the relative proportion of the major types of 
bacteria was different in comparison to overweight and 
obese children. The number of bacteria classified to 
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Firmicutes phylum (Lactobacillus and Clostridium gen-
era) was lower when compared to the previous group 
and accounted for on average 39.1% of the bacterial 
population investigated. Bacteria from genera Clostrid­
ium and Lactobacillus accounted for 18.4% and 20.7% of 
bacterial population from the five bacteria genera tested. 
The 39% of bacteria was classified to Bacteroidetes phy-
lum, 22.7% to Prevotella, and 16.3% to Bacteroides. The 
Bifidobacterium strains (Actinobacteria) represented 
21.9% of total bacterial population in the stool of over-
weight, obese and normal weight children (Fig. 2a, 2b).
Among the group of obese children, three of them 
have a high BMI equal to 40.1. In this group of children, 
a high abundance of Firmicutes (53.8%, among them 
Lactobacillus 26.4% and Clostridium 27.4%) and low 
of Bacteroidetes (25%, among them Prevotella 11.3% 
and Bacteroides 13.6%) as well as Bifidobacteria (21%) 
when compared to slim children. However, the num-
ber of individuals in this group is too small to perform 
a statistical analysis (Fig. 2c).
RFLP and sequencing analysis. RFLP analysis of 
the 16S rRNA amplicons digested with Taq I restriction 
enzyme showed that the bacteria investigated in this 
study belong to various groups, as: Bacteroides, Bifido­
bacterium, Clostridium, Lactobacillus and Prevotella. 
Bacteria classified to one strain had identical RFLP 
pattern. It was confirmed by sequencing analysis of 
bacterial 16S rRNA amplicons, whose sequences were 
compared to nucleotide sequences of the reference bac-
terial strains obtained from National Center for Bio-
technology Information (NCBI). 
SCFA and BCFA in the stool of overweight, obese 
and normal weight children. In the stool of overweight, 
obese and lean children, lactic acid dominated. The con-
centration of lactic acid in the stool of overweight and 
obese children ranged from 0.017 to 4.351 mg g–1 of 
stool (1.35 ± 0.19 mg g–1 of stool), and in children with 
normal body weight it ranged from 0.093 to 4.909 mg g–1 
of stool (2.24 ± 0.32 mg g–1 of stool; p = 0,014) (Table II). 
The concentration of SCFAs in the stool of overweight 
and obese children ranged from 0.342 to 7.521 mg g–1 
of stool (3.59 ± 0.49 mg g–1 of stool), and BCFAs from 
0.022 to 0.896 mg g–1 of stool (0.36 ± 0.05 mg g–1 of stool) 
(Table II). The concentration of SCFAs in the stool of 
children with normal body weight was higher, ranged 
from 0.424 to 10.18 mg g–1 of stool (5.44 ± 0.76 mg g–1 of 
stool, p = 0,040), and the BCFAs concentration fluctuated 
from 0.001 to 1.151 mg g–1 of stool (0.44 ± 0.06 mg g–1 of 
stool, p = 0,741). Concentrations of formic, valeric and 
butyric acids in stool did not differ between groups. 
Similarly, concentrations of acetic and propionic acids 
were similar in both groups. 
In the stool of overweight and obese children 
isovaleric acid occurred at the highest concentration 
among BCFAs. Its concentration was equal to 0.20 mg g–1 
of stool, while the average isobutyric acid concentration 
was equal to 0.16 mg g–1 of stool (Table II). In the stool 
of children with normal body weight the concentration 
of BCFA isovaleric and isobutyric acids was similar 
and was equal to 0.20 mg g–1 of stool (p = 0.913) and 
0.23 mg g–1 of stool (p = 0.640), respectively.
The results presented in Table II showed that there 
are significant differences in intestinal microbiota 
between obese and lean children. Secondly, overweight 
and obese children have significantly disturbed com-
position of fatty acids in stool.
Fig. 1. The number of bacteria isolated from stool of overweight, 
obese and normal weight children
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Discussion
The development of obesity is hypothesized to be 
closely related to changes in intestinal microbiota and 
the current results of both experimental and clinical 
studies indicate significant differences in microbiota 
and bacterial gut metagenomes of obese adults and 
children compared with lean individuals (Backhed 
et al. 2004; Kimm et al. 2005; Ley et al. 2006; Sanz 
et al. 2008; De Filippo et al. 2010; Shen et al. 20013). 
It was demonstrated that modifications of the intes-
tinal microbiota towards the dominance of Bactero­
idetes over Firmicutes correlated with decreased body 
weight in overweight and obese individuals (Backhed 
Lactic  0.017–4.351 1.35 1.126 0.093–4.909 2.24 1.804 0.014
Acetic  0.111–1.289 0.71 0.650 0.026–3.269 1.38 1.122 0.279
Propionic  0.085–1.232 0.67 0.594 0.050–2.128 1.08 0.985 0.354
Butyric  0.014–0.543 0.40 0.381 0.030–0.948 0.33 0.299 0.446
Formic 0.008–0.660 0.20 0.199 0.010–0.484 0.21 0.154 0.645
Valeric 0.012–0.412 0.26 0.254 0.063–0.472 0.20 0.187 0.164
Total SCFA 0.342–7.521 3.59 2.708 0.424–10.18 5.44 3.974 0.040
BCFA
Isobutyric 0.048–0.341 0.16 0.100 0.020–0.545 0.23 0.200 0.640
Isovalerian 0.017–0.528 0.20 0.120 0.001–1.180 0.20 0.121 0.913
Total BCFA 0.022–0.896 0.36 0.255 0.001–1.151 0.44 0.421 0.741
Table II
SCFAs and BCFAs in the stool of overweight, obese and normal weight children.
Analysis was based on U Mann-Whitney test. Statistical significance was established at p < 0.05.
Acid












[mg g–1 stool] p
Fig. 2. Contribution of the main types of bacteria 
isolated from the stool of obese children (a), nor-
mal weight children (b), and obese 3 children at 
> 95 percentile (c)
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et al. 2004; Ley et al. 2006; Sanz et al. 2008; Turnbaugh 
et al. 2008; De Filippo et al. 2010; Diamant et al. 2011; 
Everard et al. 2013).
The composition of intestinal microbiota depends 
on many factors such as age, sex, diet, used medicines 
but also the region of the world and regional cuisine. 
The number of bacteria belonging to the main genera 
Lactobacillus, Bifidobacterium, Prevotella, Bacteroides, 
Cliostridium in the selected population of Polish chil-
dren was determined for the first time in this work. 
We found that the stool of normal weight Polish 
children contained higher number of bacteria (Prevo­
tella and Bacteroides) classified to Bacteroidetes phylum 
than stool of overweight and obese children. However, 
when we analyzed obese children separately, we found 
clear dominance of bacteria of Clostridium and Lacto­
bacillus genera classified to Firmicutes in comparison 
to Bacteroidetes (Prevotella and Bacteroides) observed 
only in three children, who have highest BMI and were 
eating food rich in animal fat. 
A consequence of changes in the proportion of types 
of bacteria in the gut microbiota ecosystem is the modi-
fication of the proper production of SCFAs, which may 
also indirectly participate in the development of obesity 
(Canfora et al. 2015; Lu et al. 2016). The results of this 
study indicated that the concentration of SCFAs in the 
stool of overweight and obese children was lower in 
comparison to the stool of normal weight children. This 
phenomenon was also demonstrated for BCFAs. 
In the stool of normal weight children, the decreas-
ing concentrations of fatty acids (excluding lactic acid) 
were observed in the following order: acetic, propionic 
and butyric acid. In stool of overweight and obese chil-
dren, these proportions were not so clear, and the pro-
pionic acid occurred at a similar concentration as acetic 
acid. The lower concentration of lactic acid in the stool 
of overweight and obese children then in the faeces of 
children with normal body mass correlated with the 
variable number of the main bacterial phyla. The higher 
concentration of lactic acid in the faeces of children 
with normal body weight was associated with a higher 
number of Bifidobacteria and comparable number of 
Lactobacillus, which is an effective producer of this acid. 
A similar relationship was demonstrated for propionic 
and acetic acid, the concentration of which was signifi-
cantly higher in the faeces of children with normal body 
weight. This observation corresponded to the higher 
number of Prevotella and Bacteroides strains. On the 
other hand, the lower concentration of butyric acid was 
associated with a lower abundance of Clostridium in the 
faeces of children with normal body mass when com-
pared to overweight and obese children. Pekmez et al. 
(2018) have shown that in faeces of obese children the 
higher concentrations of butyrate and propionate could 
be noticed when compared to lean children.
SCFAs are also ligands for the two G protein-cou-
pled receptors – GPR41 and GPR43; however, they 
exhibit a different affinity for these receptors. GPR41 
has a highest affinity toward propionic acid, followed 
by butyric and acetic acids, while the GPR43 receptor 
reacts similarly with each of these three acids (Arora 
et al. 2011). Binding of SCFAs, especially the propionic 
acid to GPR41 receptors, results in increased expres-
sion of leptin. Similarly, the binding of acetic acid to 
GPR43 receptors results in the increased secretion of 
leptin in the fatty tissue of the mice’s mesentery and 
sodium propionate increases leptin secretion by 80% 
(Backhed et al. 2004; Arora et al. 2011; Nie et al. 2018). 
The clarification of the mechanisms by which 
short-chain fatty acids (SCFAs) reduce body weight 
could help in the development of an strategy to effec-
tively control the body weight. The body weight gain 
induced by a high-fat diet might be significantly inhib-
ited by supplementation of diet with acetate, propion-
ate, butyrate or their mixture. Significant changes in 
the expression of GPR43 and GPR41, characterized 
by increase of the adipose tissue mass and reduction 
in the colon, occurred due to the supplementation of 
SCFAs. Additionally, short-chain fatty acids influenced 
the change in microorganisms proportion in faeces by 
decreasing the abundance of Firmicutes and increasing 
the abundance of Bacteroidetes (Lu et al. 2016).
In the present study, we found that the concentra-
tion of propionic acid was lower in the stool of over-
weight and obese children than in the stool of normal 
weight children. The interpretation of this finding is 
difficult. The lower concentrations of propionic acid 
may be due its increased binding to G protein-coupled 
receptors as a ligand, and thus promoting inhibition 
of lipolysis and enhanced accumulation of lipids. On 
the other hand, lower concentrations of propionic acid 
may be associated with lower leptin secretion. Unfortu-
nately, we did not measure leptin and other adipokines. 
The other interpretation of lower concentration of this 
SCFA in obese children is as a counterregulatory mech-
anism for increased caloric intake (Arora et al. 2011).
Our study has several limitations. First, we used 
conventional bacteriological methods and we do not 
assess bacterial metagenome. Second, our study group 
was small and we did not correlate our findings with 
metabolic abnormalities such as insulin resistance, dys-
lipidemia and immune activation. However, there are 
also few potential perspectives. It is interesting whether 
the interventions such as dietary modifications and/or 
increased physical activity may affect intestinal micro-
biome. Furthermore, it is important to analyze relation 
between intestinal microbiota and metabolic abnormal-
ities typical for obesity and metabolic syndrome.
Concluding, we found that intestinal microbiome of 
overweight and obese children was significantly differ-
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ent in comparison with lean children. It was accompa-
nied by significant change in SCFAs and BCFAs con-
tent in stools of overweight and obese children. This 
research has been carried out on a selected population 
of Polish children using conventional microbiological 
methods. The recent scientific reports indicate that the 
role of intestinal microbiota in the pathogenesis of obe-
sity is ambiguous and therefore it is justified to repeat 
the study on metabolome and metagenome of faecal 
samples from Polish children.
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